Lucid Diagnostics (LUCD) Revenue (2021 - 2026)

Lucid Diagnostics (LUCD) has reported Revenue for 6 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 28.98% year-over-year to $1.5 million; the trailing twelve-month figure through Jun 2026 stood at $5.5 million (up 26.49% YoY), and the FY2025 full-year result was $4.7 million, up 8.28% from the prior year.
• Revenue climbed to $1.5 million in Q2 2026 per LUCD's latest filing, from $1.3 million in the prior quarter.
• Across five years, Revenue topped out at $1.5 million in Q4 2025 and bottomed at $76000.0 in Q3 2022.
• Historically, Revenue has averaged $862176.5 across 5 years, with a median of $1.0 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Revenue slumped 62.67% in 2022, then soared 930.26% in 2023.
• Over 5 years, Revenue stood at $112000.0 in 2022, then jumped by 828.57% to $1.0 million in 2023, then climbed by 15.1% to $1.2 million in 2024, then advanced by 25.65% to $1.5 million in 2025, then fell by 0.27% to $1.5 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $1.5 million, $1.3 million, and $1.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.